Review Article

Link between Cancer and Alzheimer Disease via Oxidative Stress Induced by Nitric Oxide-Dependent Mitochondrial DNA Overproliferation and Deletion

Table 1


MarkerRoleAssociation with Alzheimer disease

Cyclin A S to G2/M [95, 96]
Cyclin B G2/M[9799]
Cyclin C No known role
Cyclin D (D1, D3)G0/G1/lateG1/S[98101]
Cyclin E G1 to G1/S[97, 102]
p34cdc2/cdk 1Late G2/M [95, 96, 103, 104]
Cdk4/Cdk6G1/G1/S[105108]
Cdk5/p25/p35G2 D1, D3 G1 Cyclins[109114]
Nclk cdc2-like kinase Cyclin A kinase[109, 115, 116]
Cdk7/MPM2CDK activated kinase[101, 117]
Cdc42/racGTPase/cell division
p21rasG protein/MAPK[118, 119]
MRG 15M phase regulator[120]
Ki-67LateG1,S,G2,M[97, 120]
p105/pRbG2/M TF[105, 120]
PCNAnon cell-cycle specific [99]
p107/pRbCdk2/4/6, check pt[77, 105] (negative association)
c-mycS to G2 checkpoint[77] (negative association)
p53/MDM2Repressor complex[118, 120, 121]
ATMCheck-point[77]
Raf/Raf-1Check point kinase[117]
p16INK4a p18p15p19CyclinD/cdk4/6
inhibitors of M phase
[101, 122]
p27/Kip1Cyclin D and E/cdk7 inhibitor[77] (negative association), [101]
WAF-1/p21/Cip1Multi-Cyclin/cdk-inhibitor (G1 and S)[118]
Plk1/cdc5
Polo-like kinase
G2/M M check point[123]
PP2A or PP2BPhosphatase (Cdk5, cdc2)[124126]
PP-1[112, 124]
Cdc25 Cdc25APhosphatase G2/M[127, 128]
PKC/Wnt pathTranslation control[129132]
PKAKinase[133, 134]
PKNKinase[135]
PI3KKinase[136, 137]
AKT/PKB/RACKinase[135, 138, 139]
TGFBeta/TAKKinase[140, 141]
p44/p42 MAPK (ERK1/2)MAP kinase[95, 142146]
CamKKinase Ca/calmodulin regulated [147]
p38 MAPKKinase[146, 148, 149]
JNK/(SAPK-2/3)-alpha gammaKinase (stress activated)[146, 150]
MEKMAPK kinase[122, 151]
GSK-3 and
beta Catenin
Proline-dependent protein kinase (PDPK)[111, 112, 131, 138, 152157]
P120/E-cadherinAdhesion complex[158]
c-fosTF/regulator[159]
14-3-3/14-3-3zetaAdaptor protein[160, 161]
c-jun/p38, AP-1TF component[159, 162, 163]
FynTranscription factor[164, 165]
p53TF/DNA damage[97, 166]
RhoG-protein[135]
Rap RabG-protein[117]
Sos-1 Guanine nucleotide exchange factor[167]
Grb-2Adaptor[167]

Modified and reprinted with permission of CNS Neurol Disord Drug Targets [92]